Skip to main content
Update Location

My Location

Update your location to show providers, locations, and services closest to you.

Enter a zip code
Or
Select a campus/region
(352) 294-5480

Kartik Cherabuddi, MD, FACP, FIDSA

Infectious Disease Specialist

Photo of Kartik Cherabuddi
(352) 294-5480 MyUFHealth

Research at a glance

Top areas of exploration

  • Anti-Bacterial Agents , 10 publications
  • COVID-19 , 5 publications
  • Vancomycin , 3 publications
  • Cefepime , 3 publications

Research activity

64 publications

1,007 citations

Why is this important?

Focus

Multidrug resistant infections

Antimicrobial alternatives to antibiotics

Therapeutic drug monitoring and personalized medicine

Emerging global infections

NTM infections in Transplant patients

Infectious disease fellow, Internal medicine resident and Medical student education

Active clinical trials

DOTS (20-0002)

This is a Phase 2b clinical study, multicenter, randomized, open-label, assessor-blinded, superiority study. The study will compare dalbavancin to standard of care antibiotic therapy for the completion of therapy in patients with complicated…

Investigator
Kartik Cherabuddi
Status
Accepting Candidates
Ages
18 Years - 99 Years
Sexes
All

My publications

64 publications

2024

Brincidofovir for disease progression due to suspected tecovirimat resistance in association with advanced HIV.

International journal of STD & AIDS

PubMed • Publisher's site

2023

A new antifungal drug for candidaemia

The Lancet Infectious Diseases

Publisher's site

2023

Analysis of Two-Step Clostridioides Difficile Testing on Case Reporting, Cycle Threshold Value and Treatment Choice

American Journal of Infection Control

Publisher's site

2023

Digital cough monitoring - A potential predictive acoustic biomarker of clinical outcomes in hospitalized COVID-19 patients.

Journal of biomedical informatics

PubMed • Publisher's site

2023

Efficacy of Messenger RNA-1273 Against Severe Acute Respiratory Syndrome Coronavirus 2 Acquisition in Young Adults From March to December 2021.

Open forum infectious diseases

PubMed • Publisher's site